Error message

The page you requested does not exist. For your convenience, a search was performed using the query events thu 21 mar 0930 demographics diagnosis treatment pathways haematological malignancies.

Search results

  1. Dr Catherine Lindon

    ... role of substrate proteolysis in the precisely coordinated events giving rise to two daughter cells at the end of mitosis. The Aurora ...

  2. Dr Athena Matakidou

    ... modify the mouse renal apithelium and replicate the genetic events observed in human renal cell carcinoma. The development of reproducible ...

  3. Dr Mariann Bienz

    ... cell compartment. Our aim is to understand the molecular events underlying Wnt signal transduction. We focus on positively-acting ...

  4. Dr Dario Bressan

    ... for the spatial and temporal control of biological events in vivo. Specifically, I am using photochemically caged ligands and ...

  5. Dr Frank McCaughan

    My research is focused on understanding the early driver events that are critical to the development of squamous lung cancer (SQC) and ...

  6. Professor Gillian Murphy

    ... by trafficking which allows specific localisation in events such as cell invasion. The identification of the importance of specific ...

  7. Dr James Nathan

    Cellular mechanisms of oxygen and metabolite sensing: ...

  8. Dr James Rudd

    ... arteries as a predictor of plaque rupture and clinical events. Additionally, I use non-invasive imaging methods such as PET, MRI and ...

  9. Ms Paola Marco

    ... The inhibitor can be washed out, allowing us to study events in a more flexible way. I will introduce these mutants in RPE cells to ...

  10. Dr Marisa Segal

    ... morphogenesis in S. cerevisiae we have focused on the events that determine SPB asymmetry or spindle polarity, i.e. the mechanisms ...

  11. Dr David Gilligan

    David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

  12. Mr David Thurtle

    Radiological assessment of prostatic osseous metastases. Robotic-assisted laparoscopic prostatectomy. Early detection of prostate cancer. Risk Prediction in prostate cancer

  13. Professor David Glover

    Our laboratory studies the regulation of progression through mitosis and meiosis in animal cells. The high degree of evolutionary conservation of these regulatory mechanisms means that findings in model organisms are readily applicable to human cells....

  14. Dr Roisin Owens

    Our group works on integrating biological models with electronic devices to generate systems that can be predictive of real biological systems, for drug discovery and therapeutics. We combine expertise in a wide range of disciplines including...

  15. Mr Thierry Lefebvre

    Radiotherapy is often prescribed in oncology clinics to treat solid tumours and to limit the development and the propagation of cancer cells. The lack of oxygenation seen in some tumour regions under chaotic and unrestricted cellular growth constitute a...

  16. Professor Walid Khaled

    My laboratory works on defining the early cellular and molecular events that drive tumour initiation and development. In particular, we focus on how the cell of origin affects the differentiation trajectory of nascent tumour cells and dictates changes...

  17. Mr Adam Palmer

  18. Dr Avgi Andreou

  19. Miss Alicia Garcia Gimenez

  20. Mr Adrian Lascu

  21. Miss Aleksandra Kruglikov

  22. Dr Andrew Reynolds

  23. Mr Angelos Kolias

    Angelos Kolias is a Clinical Senior Lecturer and Consultant Neurosurgeon in the Department of Clinical Neurosciences, Addenbrooke’s Hospital and University of Cambridge, Cambridge, UK. He also holds an adjunct Professorship at Humanitas University,...

  24. Dr Antony Rix

    Co-founded by Prof Evis Sala and Dr Antony Rix, Lucida Medical is a spin-out from the University of Cambridge Department of Radiology and Cambridge University Hospitals. The company develops AI-based software to help automate the analysis of...

  25. Professor Tony Green

    Tony Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He was appointed Head of the University Department of Haematology (2000-2020), and in 2016 was appointed Director...

  26. Dr Anna-Maria Shiarli

  27. Dr Alejandra Bruna

    We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...

  28. Dr Aisling Redmond

    Aisling received her undergraduate degree in Genetics from Trinity College Dublin and PhD from Dublin City University. She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK...

  29. Miss Amara Cañizares

  30. Professor Alan Warren

    Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome,...

  31. Ms Ala Alenazi

    Regulation of Mammary gland development

  32. Dr Alex Martin

  33. Miss Andrea Martos Esteban

  34. Dr Andrew Pierce

    DNA damage and repair, oncology clinical biomarkers

  35. Mr Andrew Hindmarsh

    .

  36. Dr Ashwin Seshia

    ... and microfluidics based platforms for early diagnosis. We also research microfabricated biophysical tools to characterise ...

  37. Dr Anna Piskorz

    ... helping in better patient stratification, earlier disease diagnosis, monitoring patient response and improving patient management during ...

  38. Dr Andre Neves

    ... in the use of molecular imaging techniques for early cancer diagnosis and for better assessing response to cancer therapy. Currently, I'm ...

  39. Dr David Fairen-Jimenez

    ... has a fundamental impact to revolutionise cancer diagnosis and therapy. Our objective is to evaluate new strategies in the study ...

  40. Dr Daniel Munoz-Espin

    ... also developing novel tools and nanodevices for cancer early diagnosis and therapy. For people interested in joining my laboratory, ...

  41. Professor Fiona Gilbert

    ... I am interested in new techniques which offer more accurate diagnosis or new insights into the tumour microenvironment. My experience with ...

  42. Dr Honglin Song

    ... to the risk of ovarian cancer and clinical outcome after a diagnosis of ovarian cancer. I have led the work of the group in common/rare ...

  43. Dr John Suckling

    ... MRI is a fundamental clinical tool for brain tumour diagnosis and monitoring, the spatially extended topography of brain networks ...

  44. Dr Juliet Usher-Smith

    My research focuses on the use of risk prediction models to promote behaviour change to help prevent cancer and inform stratified screening programmes.

  45. Dr Alison Dunning

    ... for genetic risk factors for both cancer susceptibility and treatment-response. In this we collaborate closely with the international ...

  46. Dr Alexey Larionov

    Hormonal treatment and resistance in Breast cancer Heritable cancer predisposition ...

  47. Dr Anny Wong

    ... of the paediatric day unit where children come for their treatment and investigations. She also specialises in the follow-up care of children who have finished their cancer treatment. ...

  48. Dr Richard Benson

    ... cancers, develpoing technical radiotherapy and evaluating treatment related toxicity. ...

  49. Dr Basma Greef

    Supervisor Prof Margaret Ashcroft. Disruption of hypoxia response pathways in renal cancer and how these can be harnessed to develop new treatments. My other interests include clinical trials and the effective management of toxicities related to widely...

  50. Professor Brian Huntly

    ... to identify and validate targets which will allow specific treatment of leukaemia and cancer stem cells with acceptable side-effects on ...

  51. Professor Kevin Brindle

    ... to immunotherapy. An early apoptotic response following treatment with a chemotherapeutic drug is a good prognostic indicator for treatment outcome. Therefore, a major focus is the development of magnetic ...

  52. Professor Anna Philpott

    ... in stem cell and developmental models, will illuminate the pathways that are disrupted in tumorigenesis and point the way to new ...

  53. Dr Adrian Kelly

    ... MHC class I and class II antigen processing and presentation pathways. ...

  54. Professor Carlos Caldas

    ... of these cancer stem cells and their disrupted pathways is one of our research priorities. In parallel we will continue to ...

  55. Professor Christine Watson

    ... gland biologist with a particular interest in the signaling pathways that regulate mammary gland development and lineage commitment of ...

  56. Dr Simon Cook

    ... we are interested in how protein kinase and lipid signalling pathways control cell fate decisions such as proliferation versus differentiation and survival versus death. However, these pathways are frequently de-regulated in human cancer due to mutations in growth ...

  57. Dr David Adams

    ... performs forward genetic screens to uncover cancer genes and pathways and leads a programme to decode the genomes of several mouse strains. ...

  58. Dr Darerca Owen

    ... regulators. These proteins control many signal transmission pathways that can become deregulated in cancer and other diseases. We focus or ...

  59. Professor David Rowitch

    ... diseases has emerged from investigation of normal pathways of brain development. Dr. Rowitch's laboratory investigates Sonic ...

  60. Dr Daniel Hodson

    ... factors) and by the activation of oncogenic signalling pathways that regulate the activity of these translation factors. Finally we ...

  61. Dr Joanna Baxter

    ... and nucleic acid samples, the majority from patients with haematological malignancy and clonal blood cell disorders; and the remainder, ... expand collection of patient samples to cover all types of haematological malignancy, to consolidate all samples collected since 1992 by ...

  62. Professor George Vassiliou

    ... the pre-clinical evolution, pathogenesis and treatment of haematological malignancies with a particular focus on acute myeloid leukaemia ... Hospital in Cambridge where I treat patients with haematological cancers. ...

  63. Dr Liz Hook

    ... at CUHNHSFT. My particular fields of interest are solid and haematological paediatric neoplasms. I am joint training lead for the ...

  64. Dr Michael Gattens

    ... for the care of children with malignant and non-malignant haematological conditions, accepting referrals from the East of England region. ...

  65. Professor Simon Mendez-Ferrer

    ... and how the deregulation of these mechanisms contributes to haematological disorders. The group has demonstrated that the brain regulates a ...

  66. Dr Anne Warren

    ... and assessment for research projects of the urological malignancies research programme. ...

  67. Dr Ingo Ringshausen

    We study the interaction between malignant B cells and cells of the microenvironment to understand signalling pathways mediating the generation of tumour supportive niches. These niches are particularly important for microenvironment-mediated drug...

  68. Dr Kate Fife

    ... Hospitals. She carried out clinical research in HIV related malignancies and completed an MD in angiogenesis related research at Chelsea ...

  69. Professor Klaus Okkenhaug

    ... is already approved for the treatment of certain B cell malignancies (CLL, SLL, FL) and PI3Kdelta inhibitors are also being trialled as ...

  70. Dr Nitzan Rosenfeld

    ... as a noninvasive modality to assess evolution of solid malignancies. The study of ctDNA is complicated by the presence of overwhelming ...

  71. Dr Simon Richardson

    ... and epigenetic dysregulation underlying aggressive B cell malignancies, focussing on B acute lymphoblastic leukaemia, the commonest ...

  72. Mr Shanlin Tong

    ... on understanding the PI3K signaling pathway's role in B cell malignancies' development, utilizing advanced techniques such as flow ...

  73. Professor Suzanne Turner

    ... cases also associated with EBV infection. Whether these 2 malignancies are biologically similar remains to be determined and is an area ...

Pages